Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical Biology

被引:465
作者
Gerwick, William H. [1 ,2 ]
Moore, Bradley S. [1 ,2 ]
机构
[1] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA
[2] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA
来源
CHEMISTRY & BIOLOGY | 2012年 / 19卷 / 01期
关键词
GENE-CLUSTER; PROTEASOME INHIBITOR; MICROBIAL SYMBIONT; CYCLIC PEPTIDE; ASSEMBLY-LINE; BIOSYNTHESIS; SALINOSPORAMIDE; PATHWAY; METABOLITES; MOLECULES;
D O I
10.1016/j.chembiol.2011.12.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Marine life forms are an important source of structurally diverse and biologically active secondary metabolites, several of which have inspired the development of new classes of therapeutic agents. These success stories have had to overcome difficulties inherent to natural products-derived drugs, such as adequate sourcing of the agent and issues related to structural complexity. Nevertheless, several marine-derived agents are now approved, most as "first-in-class" drugs, with five of seven appearing in the past few years. Additionally, there is a rich pipeline of clinical and preclinical marine compounds to suggest their continued application in human medicine. Understanding of how these agents are biosynthetically assembled has accelerated in recent years, especially through interdisciplinary approaches, and innovative manipulations and re-engineering of some of these gene clusters are yielding novel agents of enhanced pharmaceutical properties compared with the natural product.
引用
收藏
页码:85 / 98
页数:14
相关论文
共 98 条
[1]   Modern methods to produce natural-product libraries [J].
Abel, U ;
Koch, C ;
Speitling, M ;
Hansske, FG .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) :453-458
[2]  
[Anonymous], 2011, GOODMAN GILMANS PHAR
[3]   Distinguishing Endogenous D-Amino Acid-Containing Neuropeptides in Individual Neurons Using Tandem Mass Spectrometry [J].
Bai, Lu ;
Romanova, Elena V. ;
Sweedler, Jonathan V. .
ANALYTICAL CHEMISTRY, 2011, 83 (07) :2794-2800
[4]   Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia [J].
Barter, Philip ;
Ginsberg, Henry N. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (08) :1040-1045
[5]   CONTRIBUTIONS TO THE STUDY OF MARINE PRODUCTS .45. SPONGE NUCLEIC ACIDS [J].
BERGMANN, W ;
WATKINS, JC ;
STEMPIEN, MF .
JOURNAL OF ORGANIC CHEMISTRY, 1957, 22 (11) :1308-1313
[6]   20S proteasome and its inhibitors: Crystallographic knowledge for drug development [J].
Borissenko, Ljudmila ;
Groll, Michael .
CHEMICAL REVIEWS, 2007, 107 (03) :687-717
[7]   Fractionated marine invertebrate extract libraries for drug discovery [J].
Bugni, Tim S. ;
Harper, Mary Kay ;
McCulloch, Malcolm W. B. ;
Reppart, Jason ;
Ireland, Chris M. .
MOLECULES, 2008, 13 (06) :1372-1383
[8]   Biosynthetic pathway and gene cluster analysis of curacin A, an antitubulin natural product from the tropical marine cyanobacterium Lyngbya majuscula [J].
Chang, ZX ;
Sitachitta, N ;
Rossi, JV ;
Roberts, MA ;
Flatt, PM ;
Jia, JY ;
Sherman, DH ;
Gerwick, WH .
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (08) :1356-1367
[9]   The barbamide biosynthetic gene cluster: a novel marine cyanobacterial system of mixed polyketide synthase (PKS)-non-ribosomal peptide synthetase (NRPS) origin involving an unusual trichloroleucyl starter unit [J].
Chang, ZX ;
Flatt, P ;
Gerwick, WH ;
Nguyen, VA ;
Willis, CL ;
Sherman, DH .
GENE, 2002, 296 (1-2) :235-247
[10]   Drugging challenging targets using fragment-based approaches [J].
Coyne, Anthony G. ;
Scott, Duncan E. ;
Abell, Chris .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (03) :299-307